David Marino

About

David Marino is senior executive managing director and co-founder of Hughes Marino, and co-leads the HM Science team. David specializes in high-value, time-critical and complex transactions for biotech, medical device, instrumentation and healthcare companies. He is an expert in the strategic planning, market assessment, financial analysis, business terms structuring and negotiations aspects of commercial real estate.

After finishing his MBA at USC, David began his commercial real estate career with Trammell Crow Company in 1989, during which David leased the properties for Hybritech’s R&D and manufacturing space. In 1990, David completed his first career tenant representation project for Baxter Healthcare for 25,000 square feet. It was that experience that sparked David’s passion for tenant representation and helped him realize the value that his MBA training and landlord experience would bring to tenants. David has been exclusively representing tenants since 1991, completing over 20,000,000 square feet, comprised of over 3,000 transactions globally.

Selected public company past projects include:

• Acutus – 50,000 SF
• Axonics – Four-building campus totaling 80,000 SF & 120,000 SF
• Cue – 20,000 SF, 32,000 SF, 65,000 SF & 180,000 SF
• Evofem – 32,000 SF
• Tracon – 4,000 SF, 7,000 SF & 9,000 SF

Selected venture-backed and private equity funded past projects include:

• ARS Pharmaceuticals – 5,000 SF
• BioLegend – 300,000 SF owned and leased research and production lab campus
• Biosplice – 25,000 SF, 46,000 SF & 86,000 SF
• Certis Oncology – 4,000 SF and 11,000 SF
• JenaValve – 57,000 SF
• Sekisui Diagnostics – 23,000, 45,000 SF & 52,000 SF
• Vyaire Medical – Global real estate provider for 40 locations globally from 2,000-400,000 SF
• Xifin – 15,000 SF, 32,000 SF & 58,000 SF